Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Invested Capital: 2016-2024

Historic Invested Capital for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $293.4 million.

  • Collegium Pharmaceutical's Invested Capital rose 13.56% to $339.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.4 million, marking a year-over-year increase of 13.56%. This contributed to the annual value of $293.4 million for FY2024, which is 22.53% down from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Invested Capital is $293.4 million, which was down 22.53% from $378.8 million recorded in FY2023.
  • Collegium Pharmaceutical's Invested Capital's 5-year high stood at $769.8 million during FY2022, with a 5-year trough of $293.4 million in FY2024.
  • Over the past 3 years, Collegium Pharmaceutical's median Invested Capital value was $378.8 million (recorded in 2023), while the average stood at $480.7 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Invested Capital skyrocketed by 281.89% in 2020, and later slumped by 50.80% in 2023.
  • Collegium Pharmaceutical's Invested Capital (Yearly) stood at $348.5 million in 2020, then dropped by 0.53% to $346.7 million in 2021, then soared by 122.06% to $769.8 million in 2022, then slumped by 50.80% to $378.8 million in 2023, then decreased by 22.53% to $293.4 million in 2024.